Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
12,086,885
Number of holders
25
Total 13F shares, excl. options
4,289,195
Shares change
-118,536
Total reported value, excl. options
$5,381,803
Value change
-$131,941
Put/Call ratio
0%
Number of buys
5
Number of sells
-13
Price
$1.26

Significant Holders of HOOKIPA Pharma Inc. - Common Stock, par value $0.0001 per share (HOOK) as of Q2 2025

34 filings reported holding HOOK - HOOKIPA Pharma Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
HOOKIPA Pharma Inc. - Common Stock, par value $0.0001 per share (HOOK) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,289,195 shares of 12,086,885 outstanding shares and own 35% of the company stock.
Largest 10 shareholders include GILEAD SCIENCES, INC. (1,875,945 shares), BAKER BROS. ADVISORS LP (812,814 shares), Siren, L.L.C. (566,640 shares), FMR LLC (334,030 shares), VANGUARD GROUP INC (300,819 shares), GEODE CAPITAL MANAGEMENT, LLC (73,341 shares), ACADIAN ASSET MANAGEMENT LLC (55,735 shares), Ikarian Capital, LLC (52,996 shares), RENAISSANCE TECHNOLOGIES LLC (45,570 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (37,265 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.